## 4 Empirical Analysis
### Discussion
In addition, the aspect of CR can be improved by the RS aspect based on the fourth development path (RS[1]\(\rightarrow\)CR[4]\(\rightarrow\)ME[3]), as illustrated in Table 12.  
The aspect of OM can be improved by the RS aspect and ME (market expansion) aspect can be improved by the PC aspect, based on the fifth development path (RS[1]\(\rightarrow\)OM[5]\(\rightarrow\)PC[2]\(\rightarrow\)ME[3]), as illustrated in Table 12. Further, the aspect of CR can be improved by the RS aspect and ME aspect can be improved by the PC, based on the sixth development path (RS[1]\(\rightarrow\)CR[4]\(\rightarrow\)PC[2]\(\rightarrow\)ME[3]), as illustrated in Table 12. The aspect of CR (critical resources) can be improved by the RS based on the seventh development path (RS[1]\(\rightarrow\)CR[4]\(\rightarrow\)OM[5]\(\rightarrow\)ME[3]), as illustrated in Table 12. In addition, the aspect of CR can be improved by the aspect of RS and ME aspect can be improved by the PC, based on the eighth development path (RS[1]\(\rightarrow\)CR[4]\(\rightarrow\)OM[5]\(\rightarrow\)PC[2]\(\rightarrow\)ME[3]), as illustrated in Table 12.  
Therefore, the AIA-NRM approach integrates the AI development paths and the II development paths; the best-suited development paths are illustrated in Table 12. Because the AI development paths and II development paths are the same in the empirical result, the best-suited development paths include the eight development paths (RS\(\rightarrow\)ME; RS\(\rightarrow\)PC\(\rightarrow\)ME; RS\(\rightarrow\)OM\(\rightarrow\)ME; RS\(\rightarrow\)CR\(\rightarrow\)ME; RS\(\rightarrow\)CR\(\rightarrow\)PC  
1. RS and PC are located in the second quadrant (L, H). That means RS and PC are low acquisition and high importance. Therefore, the development strategy B (in-house development) can apply to the aspect of RS and PC. Regarding the net influence effect, the RS influences the CR, OM, PC, and ME. The RS aspect is the most dominant of all aspects. The regulatory system in the Med-Tech industry is not only the most critical challenge but also very difficult to overcome. Med-Tech enterprises consider the regulatory system as their first priority of digital transformation and develop it by themselves. 2. The CR and ME located in the third quadrant (L, L). They both difficult to attain but less important. That means the development strategy C (maintain status) can apply to the aspect of CR and ME. ME in the Med-Tech industry does not dominate any other aspect. It fails to show any specific pathway to follow. The med-Tech industry is different than in other industries. ME has to be conservative. The strategy is suggested as maintain status. 3. The OM is located in the fourth quadrant (H, L). Unexpectedly, the accessibility of OM is high. The development strategy D (strategic alliance) can apply to the aspect of OM. Med-Tech enterprise should consider strategic alliance with other suppliers. Moreover, the NRM approach can help the enterprise to find the pathway of digital transformation. This study finds out that there are eight suited paths for Med-Tech enterprises to select as the priority to consider enhancement, including RS\(\rightarrow\)ME, RS\(\rightarrow\)PC\(\rightarrow\)ME, RS\(\rightarrow\)OM\(\rightarrow\)ME, RS\(\rightarrow\)CR\(\rightarrow\)ME, RS\(\rightarrow\)OM\(\rightarrow\)PC\(\rightarrow\)ME, RS\(\rightarrow\)CR\(\rightarrow\)OM\(\rightarrow\)ME, and RS\(\rightarrow\)CR\(\rightarrow\)OM\(\rightarrow\)PC\(\rightarrow\)ME. The regulatory system is in the first place of all these eight paths. The importance of the regulatory system makes the Med-Tech industry different than other industries. Med-Tech enterprises have to attend certain regulations in order to produce particular products. Among all kinds of competitive improved transformation, Med-Tech enterprise will gain the most benefit by transforming for gaining the certificate from the regulatory system. The regulatory system plays as a threshold of qualification.